Commitment of $30M from AbbVie supports research collaboration with Harvard Medical School to advance development of therapeutics

How a new vaccine adjuvant might spare doses and shorten the race to COVID-19 immunity

Collaboration seeks to explore fundamental immunological processes and identify potential therapeutic opportunities

Harvard, Merck to collaborate on research led by Harvard immunologist Arlene Sharpe, seeking to identify new pathways for the treatment of cancer